Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
89 studies found for:    "Tobacco, Smokeless" | Open Studies
Show Display Options
Rank Status Study
21 Not yet recruiting Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg
Condition: Type 2 Diabetes
Intervention: Drug: Evogliptin, Pioglitazone, Evogliptin+Pioglitazone
22 Recruiting Retrospective Evaluation of CML Patients in the National Compassionate Program
Conditions: Chronic Myeloid Leukemia;   Philadelphia Positive
Intervention: Drug: Ponatinib
23 Recruiting Thermic Effects of Some Scottish Plant Foods
Conditions: Diet Induced Thermogenesis;   Obesity Control
Interventions: Dietary Supplement: Control Meal;   Dietary Supplement: Berry Treatment;   Dietary Supplement: Sea Buckthorn Treatment;   Dietary Supplement: Wild Garlic Treatment
24 Recruiting Culturally Grounded Early Substance Use Prevention for American Indian Families
Condition: Substance Use
Interventions: Behavioral: Lakota Language enhancement;   Behavioral: Facebook Supplement;   Behavioral: Substance Use Resistance Skills
25 Recruiting Impact of Physiological, Lifestyle and Genetic Factors on Body Composition
Condition: Body Composition, Beneficial
26 Recruiting Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon
Condition: Ruptured Achilles Tendon
Interventions: Procedure: operative;   Procedure: non-operative
27 Recruiting Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia
Conditions: Schizoaffective and Schizophreniform Disorders;   Schizophrenia
Interventions: Drug: Ondansetron;   Drug: Placebo
28 Recruiting Comparison Between Four Types of Single Dose Hyaluronic Acid Injection in Patients With Knee Osteoarthritis
Condition: Osteoarthritis
Interventions: Drug: Crespine gel;   Drug: Intragel;   Drug: Crespine plus gel;   Drug: Monovisc
29 Recruiting Non Touch Technique for IUD Insertion
Condition: Contraception
Intervention: Device: intrauterine device TCu 380A
Conditions: Chronic Hepatitis, B Virus;   Carrier of Viral Hepatitis Type B
Intervention: Drug: Peginterferon Alfa-2A
31 Not yet recruiting Intracochlear Potentials: Volta Study
Condition: Hearing Loss
Interventions: Device: SA16 research software;   Device: CS19 (1.6.2)
32 Recruiting Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
Conditions: Acute Lymphoblastic Leukemia;   Complete Hematologic Remission (CHR);   Persistent/Recurrent Minimal Residual Disease (MRD)
Intervention: Other: Autologous NK cells infusions
33 Recruiting A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Biological: Ocrelizumab
34 Recruiting REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)
Conditions: Huntington Disease;   Huntington's Disease
35 Recruiting Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Ocrelizumab
36 Recruiting "AIDA" Protocol (LAP 0493)
Condition: Leukemia
Intervention: Drug: all-trans retinoic acid (ATRA)
37 Recruiting Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
Condition: Urothelial Carcinoma
Interventions: Drug: Atezolizumab;   Drug: Carboplatin;   Drug: Gemcitabine;   Other: Placebo;   Drug: Cisplatin
38 Recruiting Riociguat in Scleroderma Associated Digital Ulcers
Conditions: Scleroderma;   Digital Ulcers
Interventions: Drug: Riociguat;   Drug: Placebo
39 Recruiting Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.
Condition: Phobia, Specific
Interventions: Drug: Valproic Acid;   Drug: Placebo;   Behavioral: Fear reactivation;   Behavioral: No fear reactivation
40 Recruiting MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate
Conditions: Untreated Philadelphia Positive Acute Lymphoblastic Leukemia;   De Novo;   Secondary;   Low-dose Corticosteroids Pretreatment
Interventions: Drug: Prephase PDN + CY;   Drug: Cycle 1 Induction;   Drug: Cycle 2 Induction / Early consolidation;   Drug: Cycle 3 Early consolidation;   Drug: Cycle 4 Consolidation;   Drug: Cycle 5 Consolidation;   Drug: Cycle 6 Consolidation;   Drug: Cycle 7 Consolidation;   Drug: Cycle 8 Reinduction;   Drug: Maintenance;   Procedure: Allogeneic SCT or Autologous SCT

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.